1. Home
  2. CVV vs PASG Comparison

CVV vs PASG Comparison

Compare CVV & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVD Equipment Corporation

CVV

CVD Equipment Corporation

HOLD

Current Price

$4.14

Market Cap

28.5M

Sector

Technology

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$8.82

Market Cap

28.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVV
PASG
Founded
1982
2017
Country
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.5M
28.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CVV
PASG
Price
$4.14
$8.82
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$34.50
AVG Volume (30 Days)
90.2K
50.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.46
$5.12
52 Week High
$5.86
$20.00

Technical Indicators

Market Signals
Indicator
CVV
PASG
Relative Strength Index (RSI) 47.12 40.78
Support Level $3.80 $8.44
Resistance Level $4.77 $9.32
Average True Range (ATR) 0.42 1.26
MACD -0.11 -0.19
Stochastic Oscillator 16.30 20.96

Price Performance

Historical Comparison
CVV
PASG

About CVV CVD Equipment Corporation

CVD Equipment Corp is engaged in the manufacturing of chemical vapor deposition equipment, customized gas control systems, the manufacturing of process equipment suitable for the synthesis of a variety of one-dimensional nanostructures and nanomaterials and a line of furnaces, all of which are used to produce semiconductors and other electronic components. The company operates through the segments of CVD Equipment, CVD materials, and Stainless Design Concepts, MesoScribe. It generates maximum revenue from the CVD Equipment segment. The CVD Equipment segment manufactures and sells chemical vapor deposition, physical vapor transport, and similar equipment. Company operates in USA, North America, Europe, Middle East and Africa, and Asia-Pacific.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: